e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Clinical features of human pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting survival in pulmonary hypertension in the United Kingdom: Comparison of prognostic equations
W. T. N. Lee, Y. Ling, K. Sheares, J. Pepke-Zaba, A. Peacock, M. Johnson (Glasgow, Cambridge, United Kingdom)
Source:
Annual Congress 2011 - Clinical features of human pulmonary hypertension
Session:
Clinical features of human pulmonary hypertension
Session type:
Oral Presentation
Number:
4915
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. T. N. Lee, Y. Ling, K. Sheares, J. Pepke-Zaba, A. Peacock, M. Johnson (Glasgow, Cambridge, United Kingdom). Predicting survival in pulmonary hypertension in the United Kingdom: Comparison of prognostic equations. Eur Respir J 2011; 38: Suppl. 55, 4915
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in
incident
idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Late-breaking abstract: Demographic trends and changes In long term outcome of
incident
idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Idiopathic pulmonary fibrosis mortality in the United States: is there any evidence of occupational risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 702s
Year: 2005
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017
Year: 2017
Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016
Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Validation of a prognostic score for pulmonary embolism short-term mortality
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry
Source: Eur Respir J, 53 (2) 1801677; 10.1183/13993003.01677-2018
Year: 2019
Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013
Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017
Year: 2018
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model
Source: Eur Respir J 2016; 48: 780-786
Year: 2016
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model
Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018
Year: 2018
Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Source: Eur Respir J 2010; 35: 1079-1087
Year: 2010
Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept